Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/17/2003WO2003031595A3 Molecules for disease detection and treatment
07/17/2003WO2003025197A3 Mutant sh3-binding protein compositions and methods
07/17/2003WO2003018800A3 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
07/17/2003WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
07/17/2003WO2002083928A3 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
07/17/2003WO2002081646A3 Epitope sequences
07/17/2003WO2002081633A3 A bardet-biedl susceptibility gene and uses thereof
07/17/2003WO2002079450A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
07/17/2003WO2002077233A8 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF
07/17/2003WO2002058589A3 Agents and methods for promoting bone growth
07/17/2003WO2002057450A3 Proteins and nucleic acids encoding same
07/17/2003WO2002047478A3 Transgenic mice containing proliferator-activated receptor gene disruptions
07/17/2003WO2002039947A3 Carrier vectors through an epithelium with tight junctions
07/17/2003WO2002038803A3 Novel marker for the diagnosis and therapy of tumours
07/17/2003WO2002032962A3 Compositions of human proteins and method of use thereof
07/17/2003WO2002029060A9 Hematopoietin receptors hpr1 and hpr2
07/17/2003WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses
07/17/2003WO2002022660A3 Novel nucleic acids and polypeptides
07/17/2003WO2002006479A3 Apoptosis-inducing dna sequences
07/17/2003WO2001064869A9 Tumor-related antigen
07/17/2003WO2001062891A3 207 human secreted proteins
07/17/2003WO2001051628A9 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
07/17/2003US20030135890 Nucleic acids that control plant development
07/17/2003US20030135888 Nucleotide sequences for controlling expression of RNA sequences in rice plants; antisense agents; genetic suppressor sequences
07/17/2003US20030135887 Plant bioreactors
07/17/2003US20030135881 Quantitative trait loci associated with soybean cyst nematode resistance and uses thereof
07/17/2003US20030135879 Methods and materials for making and using transgenic dicamba-degrading organisms
07/17/2003US20030135878 Transgenic plants with elevated thioredoxin levels
07/17/2003US20030135877 Sugar and lipid metabolism regulators in plants
07/17/2003US20030135873 Transgenic animal model coding fusion protein comprising nuclear protein and herpes viral vp16 protein; antidiabetic agents; uncoupling proteins
07/17/2003US20030135053 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics
07/17/2003US20030135037 Plasmid comprising chimeric paracrystalline surface layer protein fused to infectious hematopoietic necrosis virial proteins; nonpathogenic gene transfer vechile
07/17/2003US20030135036 Platelet glycoprotein v gene and uses
07/17/2003US20030135034 Nucleotide sequences coding extracellular membrane proteins; antitumor agents; antiproliferative agents; antiiiflammatory agents; enterotoxins; neuroprotectants
07/17/2003US20030135028 Human serine protease and serpin polypeptides
07/17/2003US20030135027 Mammalian imidazoline receptor
07/17/2003US20030135026 Compounds and methods for diagnosis of tuberculosis
07/17/2003US20030135025 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134815 Adenovirus mediated transfer of genes to the gastrointestinal tract. In particular, the present invention relates to a method of recombinant, replication-deficient adenovirus mediated transfer of therapuetic genes to the
07/17/2003US20030134812 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
07/17/2003US20030134799 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
07/17/2003US20030134797 Intestinal trefoil factors and nucleic acids encoding intestinal trefoil factors are disclosed. The intestinal trefoil factors disclosed are resistant to destruction in the digestive tract and can be used for the treatment of peptic
07/17/2003US20030134791 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134788 Human tumor necrosis factor receptor TR16
07/17/2003US20030134787 Engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in
07/17/2003US20030134786 Compositions for the prevention or amelioration of symptoms of anthrax. In particular, the present invention relates to TANGO 197 and/or TANGO 216 fusion polypeptides and their use as part of such methods.
07/17/2003US20030134785 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides
07/17/2003US20030134419 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
07/17/2003US20030134413 Culturing and differentiating early primitive ectoderm-like (EPL) tissues with subsequent recovery of pluripotent neurectodermal cells; gene therapy for nervous system disorders
07/17/2003US20030134407 Nucleic acids and proteins from Streptococcus pneumoniae
07/17/2003US20030134391 Highly-expressed and highly active recombinant silicatein enzyme, silicatein isolated from natural source after gene induction
07/17/2003US20030134390 An isolated polynucleotide molecule encoding an IL-21 antagonist polypeptide of specefic amino acid sequence; culturing
07/17/2003US20030134389 A polypeptide identified as fibroblast growth factor/heparin binding growth factor referred to as FGF-13 for promoting wound healing, to prevent neuronal damage associated with stroke, skin aging and to stimulate angiosenesis
07/17/2003US20030134387 Vertebrate globin
07/17/2003US20030134386 A fibronectin type III (Fn3) monobody polypeptide consisting of two to six beta -strand domains with a loop region linked between each beta-strand domain, and such polypeptide is capable of binding to a target molecule
07/17/2003US20030134385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134383 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide
07/17/2003US20030134371 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134367 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134366 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134365 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134364 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134361 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134357 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134354 Vectors with DNA encoding pro polypeptides
07/17/2003US20030134350 Zinc finger domain recognition code and uses thereof
07/17/2003US20030134346 Binding protein as biosensors
07/17/2003US20030134335 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
07/17/2003US20030134328 Mammalian genes; related reagents
07/17/2003US20030134327 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind these polypeptides
07/17/2003US20030134325 Modified phycobilisomes and uses therefore
07/17/2003US20030134323 Methods of identifying agents that affect cleavage of amyloid-beta precursor protein
07/17/2003US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above
07/17/2003US20030134310 Cellular kinase targets and inhibitors, and methods for their use
07/17/2003US20030134306 Human and murine cytokine polypeptides
07/17/2003US20030134302 Expression vectors containing expressible gene sequences can be used to transfect cells for the production of recombinant proteins
07/17/2003US20030134301 Nucleic acids, their expression products and pathways involved in pain, and their use in screening for molecule that can alleviate pain